Testing effectiveness (Phase 2)Looking for participantsNCT04040205
What this trial is testing
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Who this might be right for
ChondrosarcomaOsteosarcomaSoft Tissue Sarcoma
Medical College of Wisconsin 44